146 related articles for article (PubMed ID: 11903313)
1. Phenotypic and genetic heterogeneity of familial hyperkalaemic hypertension (Gordon syndrome).
Achard JM; Disse-Nicodeme S; Fiquet-Kempf B; Jeunemaitre X
Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1048-52. PubMed ID: 11903313
[TBL] [Abstract][Full Text] [Related]
2. A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension.
Disse-Nicodème S; Achard JM; Desitter I; Houot AM; Fournier A; Corvol P; Jeunemaitre X
Am J Hum Genet; 2000 Aug; 67(2):302-10. PubMed ID: 10869238
[TBL] [Abstract][Full Text] [Related]
3. Genetic heterogeneity of familial hyperkalaemic hypertension.
Disse-Nicodeme S; Desitter I; Fiquet-Kempf B; Houot AM; Stern N; Delahousse M; Potier J; Ader JL; Jeunemaitre X
J Hypertens; 2001 Nov; 19(11):1957-64. PubMed ID: 11677360
[TBL] [Abstract][Full Text] [Related]
4. Familial hyperkalemic hypertension (Gordon syndrome): evidence for phenotypic variability in a study of 7 families.
Disse-Nicodème S; Achard JM; Potier J; Delahousse M; Fiquet-Kempf B; Stern N; Blanchard A; Guilbaud JC; Niaudet P; Chauveau D; Dussol B; Berland Y; Dequiedt P; Ader JL; Paillard M; Grünfeld JP; Fournier A; Corvol P; Jeunemaitre X
Adv Nephrol Necker Hosp; 2001; 31():55-68. PubMed ID: 11692471
[No Abstract] [Full Text] [Related]
5. Hypercalciuria in familial hyperkalemia and hypertension accompanies hyperkalemia and precedes hypertension: description of a large family with the Q565E WNK4 mutation.
Mayan H; Munter G; Shaharabany M; Mouallem M; Pauzner R; Holtzman EJ; Farfel Z
J Clin Endocrinol Metab; 2004 Aug; 89(8):4025-30. PubMed ID: 15292344
[TBL] [Abstract][Full Text] [Related]
6. Multilocus linkage of familial hyperkalaemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21.
Mansfield TA; Simon DB; Farfel Z; Bia M; Tucci JR; Lebel M; Gutkin M; Vialettes B; Christofilis MA; Kauppinen-Makelin R; Mayan H; Risch N; Lifton RP
Nat Genet; 1997 Jun; 16(2):202-5. PubMed ID: 9171836
[TBL] [Abstract][Full Text] [Related]
7. Dehydrated hereditary stomatocytosis mimicking familial hyperkalaemic hypertension: clinical and genetic investigation.
Beaurain G; Mathieu F; Grootenboer S; Fiquet B; Cynober T; Tchernia G; Delaunay J; Jeunemaitre X
Eur J Haematol; 2007 Mar; 78(3):253-9. PubMed ID: 17253968
[TBL] [Abstract][Full Text] [Related]
8. Increased urinary Na-Cl cotransporter protein in familial hyperkalaemia and hypertension.
Mayan H; Attar-Herzberg D; Shaharabany M; Holtzman EJ; Farfel Z
Nephrol Dial Transplant; 2008 Feb; 23(2):492-6. PubMed ID: 17951312
[TBL] [Abstract][Full Text] [Related]
9. The syndrome of hypertension and hyperkalaemia with normal glomerular filtration rate: is there a deficiency in vasodilator prostaglandins?
Klemm SA; Hornych A; Tunny TJ; Gordon RD
Clin Exp Pharmacol Physiol; 1991 May; 18(5):309-13. PubMed ID: 2065475
[TBL] [Abstract][Full Text] [Related]
10. Pseudohypoaldosteronism Type II or Gordon Syndrome: A Rare Syndrome of Hyperkalemia and Hypertension With Normal Renal Function.
Manas F; Singh S
Cureus; 2024 Jan; 16(1):e52594. PubMed ID: 38374860
[TBL] [Abstract][Full Text] [Related]
11. Effect of age and affection status on blood pressure, serum potassium and stature in familial hyperkalaemia and hypertension.
Farfel A; Mayan H; Melnikov S; Holtzman EJ; Pinhas-Hamiel O; Farfel Z
Nephrol Dial Transplant; 2011 May; 26(5):1547-53. PubMed ID: 20956807
[TBL] [Abstract][Full Text] [Related]
12. The syndrome of hypertension and hyperkalaemia with normal GFR. A unique pathophysiological mechanism for hypertension?
Gordon RD
Clin Exp Pharmacol Physiol; 1986 Apr; 13(4):329-33. PubMed ID: 3524920
[TBL] [Abstract][Full Text] [Related]
13. Molecular insights from dysregulation of the thiazide-sensitive WNK/SPAK/NCC pathway in the kidney: Gordon syndrome and thiazide-induced hyponatraemia.
Glover M; O'Shaughnessy KM
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):876-84. PubMed ID: 23683032
[TBL] [Abstract][Full Text] [Related]
14. Familial hyperkalemia, hypertension, and hyporeninemia with normal aldosterone levels. A tubular defect in potassium handling.
Brautbar N; Levi J; Rosler A; Leitesdorf E; Djaldeti M; Epstein M; Kleeman CR
Arch Intern Med; 1978 Apr; 138(4):607-10. PubMed ID: 637641
[TBL] [Abstract][Full Text] [Related]
15. Syndrome of hypertension and hyperkalemia with normal glomerular filtration rate.
Gordon RD
Hypertension; 1986 Feb; 8(2):93-102. PubMed ID: 3002982
[No Abstract] [Full Text] [Related]
16. Familial hyperpotassemia and hypertension accompanied by normal plasma aldosterone levels: possible hereditary cell membrane defect.
Farfel Z; Iaina A; Rosenthal T; Waks U; Shibolet S; Gafni J
Arch Intern Med; 1978 Dec; 138(12):1828-32. PubMed ID: 718348
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of pseudohypoaldosteronism type 2 by WNK1 mutations.
Bergaya S; Vidal-Petiot E; Jeunemaitre X; Hadchouel J
Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):39-45. PubMed ID: 22080857
[TBL] [Abstract][Full Text] [Related]
18. Familiar hyperkalaemic acidosis.
Licht JH; Amundson D; Hsueh WA; Lombardo JV
Q J Med; 1985 Feb; 54(214):161-76. PubMed ID: 3885297
[TBL] [Abstract][Full Text] [Related]
19. Familial Hyperkalemia and Hypertension (FHHt) and KLHL3: Description of a Family with a New Recessive Mutation (S553L) Compared to a Family with a Dominant Mutation, Q309R, with Analysis of Urinary Sodium Chloride Cotransporter.
Kliuk-Ben Bassat O; Carmon V; Hanukoglu A; Ganon L; Massalha E; Holtzman EJ; Farfel Z; Mayan H
Nephron; 2017; 137(1):77-84. PubMed ID: 28511177
[TBL] [Abstract][Full Text] [Related]
20. [WNK1 and WNK4, new players in salt and water homeostasis].
Hadchouel J; Delaloy C; Jeunemaitre X
Med Sci (Paris); 2005 Jan; 21(1):55-60. PubMed ID: 15639021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
